AzTrials
AzTrials

This Study Aims to Examine the Effect of a Wearable Posture Corrector Device on Back Pain Body Image and Postural Awareness in Young Adult WomenNCT07816952

Young Adult Women and Wearable Posture Corrector Device

A study testing Wearable posture corrector device in people with This Study Aims to Examine the Effect of a Wearable Posture Corrector Device on Back Pain Body Image and Postural Awareness in Young Adult Women, run by Pamukkale University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

To improve posture, methods such as strengthening specific muscles or focusing on body alignment are commonly used. In addition to elastic posture correctors, electronic posture reminders can also be utilized. Read more about this study

Who is it for?
Ages 18 to 25 years, women only
What is being tested?
Wearable posture corrector device
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
No sites listed yet
Study dates
Oct 2026to Jun 2027
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Who are studying at *** University
  • Women aged 18-25 years
  • Women without spinal deformities,
  • No history of spinal surgery,
  • Back pain rated as VAS ≥ 3,
  • A Postural Awareness Scale score of ≤ 46,
  • No diagnosed psychiatric disorders,
  • No dermatological conditions that would prevent the use of the device

Who cannot join

  • Not being a student at *** University
  • Age < 18 or > 25 years
  • Presence of spinal deformity
  • Previous spinal surgery
  • Back pain VAS score < 3
  • Postural Awareness Scale score > 46
Show all 9Show fewer
  • Diagnosed psychiatric illness
  • Dermatological conditions preventing device use
  • Male sex / gender

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: The Effect of a Wearable Posture Corrector Device on Back Pain, Body Image, and Postural Awareness in Young Adult Women

To improve posture, methods such as strengthening specific muscles or focusing on body alignment are commonly used. In addition to elastic posture correctors, electronic posture reminders can also be utilized. Thanks to current wearable technologies and their companion mobile apps, individuals can enhance their posture awareness. Although studies show that wearable technologies effectively foster posture awareness, the effects of wearable posture-correcting devices on back pain (VAS) and body image are not sufficiently known. This study aims to examine the effects of a wearable posture-correcting device on back pain, body image, and posture awareness to improve posture in young adult women.

Read the detailed description

This study is a randomized controlled experimental trial with pretest-posttest measurements in experimental and control groups. The study will be conducted with young adult female students. The sample size was calculated using the G*Power software, based on a similar study that utilized the same scale (VAS). In the a priori power analysis, based on an independent samples t-test with 80% power, an alpha level of 0.05, and an effect size of 0.56, a total of 82 participants-41 in the experimental group and 41 in the control group-were required. Considering potential sample dropouts, the sample size was increased by at least 10% and finalized at a total of 90 participants.Female participants who apply to join the study, express their willingness to use the wearable posture-correcting device, and meet the inclusion criteria will be randomly assigned to the experimental and control groups according to their order of application. Data will be collected using an 'Introductory Information Form', the 'VAS' to assess back pain, the 'Body Image Scale', and the 'Postural Awareness Scale'.Data analysis will be performed using the SPSS 31.0 software package. The test of significance of the difference between two means (independent samples t-test) will be utilized to reveal the differences between the two independent groups. A significance level of alpha 0.05 will be accepted.

Being tested
Wearable posture corrector device
Keywords
Wearable Electronic Devices, Young Adult, Pain, Body Image, Posture
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Wearable posture corrector deviceDevice

    The planned device is designed for general use, requires no prescription, does not serve a clinical diagnostic or therapeutic purpose, and can be used without the need to consult a healthcare professional. The device is placed on the upper back during use. When the user assumes an incorrect posture, the device emits gentle vibrations to alert them, thereby promoting posture awareness. Women in the experimental group will use the device for a total of 4 weeks.

Study groups in NCT07816952
Study groupRoleWhat they receive
Experimental GroupActive comparatorA pretest will be administered to all participating women using the 'Introductory Information Form', the 'VAS' to evaluate back pain, the 'Body Image Scale' , and the 'Postural Awareness Scale'. Women in the experimental group will be provided with the wearable posture corrector device and instructed on how to use it. Following the completion of the intervention period, the posttest will be conducted by re-administering the 'VAS', 'Body Image Scale', and 'Postural Awareness Scale' to the experimental group.
Receives: Device: Wearable posture corrector device
Control GroupNo interventionNo intervention will be administered to the control group, and data will be collected using the same measurement instruments at the same time points.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 'Introductory Information Form'

    This form, prepared by the researchers in accordance with the literature, consists of 9 questions containing the sociodemographic data of women.

    Measured: Baseline

  2. VAS (Back Pain)

    It is a single-item, non-invasive, universally used visual analog measurement tool designed to determine pain perception. It consists of a 100 mm horizontal line, numbered from 0 representing 'no pain' to 10 representing 'unbearable pain' at either end to indicate the severity of symptoms.

    Measured: It will be administered simultaneously to participants in both the experimental and control groups at baseline and 4-weeks

  3. Body Image Scale

    The 'Body Image Scale' was developed by Saylan \& Soyyiğit (2022) to evaluate body image in individuals during adolescence and emerging adulthood and was reported to be a valid and reliable instrument. It is a 5-point Likert-type scale (1 = Strongly disagree to 5 = Strongly agree) consisting of 21 items. It comprises four subdimensions: negative body perception, evaluation sensitivity, positive body perception, and body modification. Five items of the scale (Items 4, 7, 15, 16, and 17) are reverse-scored, with the total score ranging from a minimum of 21 to a maximum of 105. Higher scores obtained from the scale indicate a more negative body image.

    Measured: It will be administered simultaneously to participants in both the experimental and control groups at baseline and 4-weeks

  4. Postural Awareness Scale

    The Turkish validity and reliability of the Postural Awareness Scale was conducted by Dursun and Önen (2018). The purpose of the scale is to assess an individual's self-reported body posture awareness. It is a 7-point Likert-type scale (ranging from 1 = 'not at all true for me' to 7 = 'completely true for me') consisting of 11 items. Items 1, 2, 3, 4, 5, and 12 of the scale are reverse-scored, and the total score obtainable ranges from a minimum of 11 to a maximum of 77.

    Measured: It will be administered simultaneously to participants in both the experimental and control groups at baseline and 4-weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Sep 2026
  2. Study startOct 2026 (estimated)
  3. Primary completionMay 2027 (estimated)
  4. Study completionJun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07816952
Sponsor's protocol ID
E-60116787-020-805093
Status last verified
Aug 2026
First submitted
8 Sep 2026
Last updated
16 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in